Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants.

Kempen DH, Lu L, Classic KL, Hefferan TE, Creemers LB, Maran A, Dhert WJ, Yaszemski MJ.

J Control Release. 2008 Aug 25;130(1):15-21. doi: 10.1016/j.jconrel.2008.05.004. Epub 2008 May 13.

2.

Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes.

Kempen DH, Yaszemski MJ, Heijink A, Hefferan TE, Creemers LB, Britson J, Maran A, Classic KL, Dhert WJ, Lu L.

J Control Release. 2009 Mar 19;134(3):169-76. doi: 10.1016/j.jconrel.2008.11.023. Epub 2008 Dec 3.

3.

Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.

Woo BH, Fink BF, Page R, Schrier JA, Jo YW, Jiang G, DeLuca M, Vasconez HC, DeLuca PP.

Pharm Res. 2001 Dec;18(12):1747-53. Erratum in: Pharm Res. 2003 Feb;20(2):334.

PMID:
11785696
4.

Characterization of absorbable collagen sponges as rhBMP-2 carriers.

Friess W, Uludag H, Foskett S, Biron R, Sargeant C.

Int J Pharm. 1999 Sep 30;187(1):91-9.

PMID:
10502616
6.

Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.

Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ.

Biomaterials. 2008 Aug;29(22):3245-52. doi: 10.1016/j.biomaterials.2008.04.031. Epub 2008 May 9.

7.

Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2.

Gruber R, Weich HA, Dullin C, Schliephake H.

Clin Oral Implants Res. 2009 Jan;20(1):24-30. doi: 10.1111/j.1600-0501.2008.01613.x.

PMID:
19126104
8.
9.

Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.

Liu HW, Chen CH, Tsai CL, Hsiue GH.

Bone. 2006 Oct;39(4):825-36. Epub 2006 Jun 16.

PMID:
16782421
10.

Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2.

Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG.

Acta Biomater. 2008 Sep;4(5):1126-38. doi: 10.1016/j.actbio.2008.04.002. Epub 2008 Apr 22.

11.

Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.

Ruhé PQ, Boerman OC, Russel FG, Spauwen PH, Mikos AG, Jansen JA.

J Control Release. 2005 Aug 18;106(1-2):162-71.

PMID:
15972241
12.

Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone.

Wang CK, Ho ML, Wang GJ, Chang JK, Chen CH, Fu YC, Fu HH.

Biomaterials. 2009 Sep;30(25):4178-86. doi: 10.1016/j.biomaterials.2009.04.029. Epub 2009 May 17.

PMID:
19447488
13.

Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics.

Chen FM, Zhao YM, Sun HH, Jin T, Wang QT, Zhou W, Wu ZF, Jin Y.

J Control Release. 2007 Mar 12;118(1):65-77. Epub 2006 Nov 24.

PMID:
17250921
14.

In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin.

Ruhé PQ, Boerman OC, Russel FG, Mikos AG, Spauwen PH, Jansen JA.

J Mater Sci Mater Med. 2006 Oct;17(10):919-27.

PMID:
16977389
15.

Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo.

Talwar R, Di Silvio L, Hughes FJ, King GN.

J Clin Periodontol. 2001 Apr;28(4):340-7.

PMID:
11314890
16.

Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat.

Cole BJ, Bostrom MP, Pritchard TL, Sumner DR, Tomin E, Lane JM, Weiland AJ.

Clin Orthop Relat Res. 1997 Dec;(345):219-28.

PMID:
9418644
17.

Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model.

Hall J, Sorensen RG, Wozney JM, Wikesjö UM.

J Clin Periodontol. 2007 May;34(5):444-51.

PMID:
17448048
18.

Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.

Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS.

Biomaterials. 2007 Jun;28(17):2763-71. Epub 2007 Mar 12.

PMID:
17350678
19.

The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation.

Bhakta G, Lim ZX, Rai B, Lin T, Hui JH, Prestwich GD, van Wijnen AJ, Nurcombe V, Cool SM.

Acta Biomater. 2013 Nov;9(11):9098-106. doi: 10.1016/j.actbio.2013.07.008. Epub 2013 Jul 19.

PMID:
23871940
20.

Enhanced bone augmentation by controlled release of recombinant human bone morphogenetic protein-2 from bioabsorbable membranes.

Lee YM, Nam SH, Seol YJ, Kim TI, Lee SJ, Ku Y, Rhyu IC, Chung CP, Han SB, Choi SM.

J Periodontol. 2003 Jun;74(6):865-72.

PMID:
12886998
Items per page

Supplemental Content

Write to the Help Desk